IL154049A0 - Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient - Google Patents
Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredientInfo
- Publication number
- IL154049A0 IL154049A0 IL15404901A IL15404901A IL154049A0 IL 154049 A0 IL154049 A0 IL 154049A0 IL 15404901 A IL15404901 A IL 15404901A IL 15404901 A IL15404901 A IL 15404901A IL 154049 A0 IL154049 A0 IL 154049A0
- Authority
- IL
- Israel
- Prior art keywords
- aryl
- active ingredient
- dementia
- remedies containing
- oxodihydropurine derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000230209 | 2000-07-31 | ||
| PCT/JP2001/006363 WO2002010167A1 (fr) | 2000-07-31 | 2001-07-24 | Medicaments contre la demence contenant des derives de 2-aryl-8-oxodihydropurine comme ingredient actif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL154049A0 true IL154049A0 (en) | 2003-07-31 |
Family
ID=18723200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15404901A IL154049A0 (en) | 2000-07-31 | 2001-07-24 | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6962921B2 (fr) |
| EP (1) | EP1306378A4 (fr) |
| KR (1) | KR100829297B1 (fr) |
| CN (1) | CN1247578C (fr) |
| AU (1) | AU7278701A (fr) |
| BR (1) | BR0112881A (fr) |
| CA (1) | CA2416706C (fr) |
| CZ (1) | CZ2003234A3 (fr) |
| HK (1) | HK1054231A1 (fr) |
| HU (1) | HUP0303714A3 (fr) |
| IL (1) | IL154049A0 (fr) |
| MX (1) | MXPA03000861A (fr) |
| NO (1) | NO20030474L (fr) |
| NZ (1) | NZ523812A (fr) |
| PL (1) | PL363870A1 (fr) |
| RU (1) | RU2277096C2 (fr) |
| SK (1) | SK1292003A3 (fr) |
| WO (1) | WO2002010167A1 (fr) |
| ZA (1) | ZA200300549B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7760101B2 (en) * | 2008-06-20 | 2010-07-20 | Kimberly-Clark Worldwide, Inc. | Method of reducing sensor corrosion in absorbent articles |
| EP2476682B1 (fr) * | 2009-09-09 | 2017-04-26 | Sumitomo Dainippon Pharma Co., Ltd. | Dérivé de 8-oxodihydropurine |
| US20140301947A1 (en) | 2011-06-06 | 2014-10-09 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
| CA2112487C (fr) * | 1991-06-26 | 2003-04-15 | James W. Young | Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur r(+) |
| US5212195A (en) * | 1992-05-13 | 1993-05-18 | Syntex (U.S.A.) Inc. | Substituted indole antagonists derivatives which are angiotensin II |
| NZ329798A (en) * | 1996-07-03 | 1999-04-29 | Japan Energy Corp | Purine derivatives their tautomers and salts thereof and interferon secretion inducers, antiviral agents and anticancer drugs containing the same |
| ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
| JP3814125B2 (ja) * | 1999-06-02 | 2006-08-23 | 大日本住友製薬株式会社 | ２−アリール−８−オキソジヒドロプリン誘導体からなる医薬 |
-
2001
- 2001-07-24 PL PL01363870A patent/PL363870A1/xx not_active Application Discontinuation
- 2001-07-24 EP EP01951985A patent/EP1306378A4/fr active Pending
- 2001-07-24 KR KR1020037001365A patent/KR100829297B1/ko not_active IP Right Cessation
- 2001-07-24 NZ NZ523812A patent/NZ523812A/en unknown
- 2001-07-24 WO PCT/JP2001/006363 patent/WO2002010167A1/fr active IP Right Grant
- 2001-07-24 US US10/343,453 patent/US6962921B2/en not_active Expired - Fee Related
- 2001-07-24 CZ CZ2003234A patent/CZ2003234A3/cs unknown
- 2001-07-24 CN CNB018163742A patent/CN1247578C/zh not_active Expired - Fee Related
- 2001-07-24 SK SK129-2003A patent/SK1292003A3/sk unknown
- 2001-07-24 HU HU0303714A patent/HUP0303714A3/hu unknown
- 2001-07-24 MX MXPA03000861A patent/MXPA03000861A/es active IP Right Grant
- 2001-07-24 IL IL15404901A patent/IL154049A0/xx unknown
- 2001-07-24 RU RU2003105827/04A patent/RU2277096C2/ru not_active IP Right Cessation
- 2001-07-24 BR BR0112881-7A patent/BR0112881A/pt not_active IP Right Cessation
- 2001-07-24 CA CA002416706A patent/CA2416706C/fr not_active Expired - Fee Related
- 2001-07-24 AU AU7278701A patent/AU7278701A/xx not_active Withdrawn
-
2003
- 2003-01-21 ZA ZA200300549A patent/ZA200300549B/en unknown
- 2003-01-30 NO NO20030474A patent/NO20030474L/no not_active Application Discontinuation
- 2003-09-10 HK HK03106435.7A patent/HK1054231A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20030474L (no) | 2003-03-27 |
| NO20030474D0 (no) | 2003-01-30 |
| AU7278701A (en) | 2002-02-13 |
| KR20030019634A (ko) | 2003-03-06 |
| EP1306378A1 (fr) | 2003-05-02 |
| CN1247578C (zh) | 2006-03-29 |
| CZ2003234A3 (cs) | 2003-05-14 |
| ZA200300549B (en) | 2003-08-19 |
| US6962921B2 (en) | 2005-11-08 |
| MXPA03000861A (es) | 2004-04-05 |
| CA2416706C (fr) | 2009-04-07 |
| WO2002010167A1 (fr) | 2002-02-07 |
| EP1306378A4 (fr) | 2005-02-09 |
| NZ523812A (en) | 2004-07-30 |
| HUP0303714A2 (hu) | 2004-03-01 |
| CN1466587A (zh) | 2004-01-07 |
| RU2277096C2 (ru) | 2006-05-27 |
| KR100829297B1 (ko) | 2008-05-13 |
| HUP0303714A3 (en) | 2007-03-28 |
| US20030166667A1 (en) | 2003-09-04 |
| PL363870A1 (en) | 2004-11-29 |
| SK1292003A3 (en) | 2003-08-05 |
| CA2416706A1 (fr) | 2002-02-07 |
| BR0112881A (pt) | 2003-07-01 |
| HK1054231A1 (zh) | 2003-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161940A0 (en) | Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient | |
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| HK1055739A1 (en) | Novel quinuclidine derivatives and medicinal compositions containing the same | |
| PL372084A1 (en) | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient | |
| IL151952A0 (en) | Aminopyridine derivatives and pharmaceutical compositions containing the same | |
| AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
| AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
| IL155196A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| AU2002226674A1 (en) | Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient | |
| IL164699A0 (en) | Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient | |
| HUP0303653A3 (en) | Tricyclic and heterocyclic derivative and pharmaceutical compositions containing them as the active ingredient | |
| AU2001232238A1 (en) | Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient | |
| AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
| HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
| AU4498201A (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain | |
| HUP0300562A3 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the | |
| AU4317500A (en) | Antibiral compositions containing phorbol derivatives as the main active ingredient | |
| MXPA02003975A (es) | Composicion farmaceutica aucosa que contiene ciclesonida. | |
| IL154986A0 (en) | Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| EP1142565A4 (fr) | Compositions therapeutiques aqueuses | |
| IL154049A0 (en) | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient | |
| AU4884701A (en) | Malonanilic acid derivatives, medicinal compositions containing the same and usethereof | |
| EP1234834A4 (fr) | Derives de 1,3,4-oxadiazoline-2-one et medicaments contenant ces derives utiles comme ingredient actif |